Ars Technica
TrumpRx delayed as senators question if it's a giant scam with Big Pharma

The Trump administration is delaying TrumpRx, an online platform for discounted prescription drugs. Senators question its legitimacy and potential conflicts of interest. Democratic senators seek oversight clarification from the Office of Inspector General.